Home
Explore NIH Technologies
Explore work by over 1,500 NIH researchers | Available for Licensing & Collaboration
Available Technologies
Available Technologies
Explore Featured Research
Get updates on the latest and most exciting research coming out of NIH...
Explore Featured Products
Novel and interesting products coming to market through NIH inventions and partnerships...
News
The Maryland Life Sciences Bio Innovation Conference is a great opportunity for global brands, venture capitalists, and promising startups to connect with top life sciences professionals in Maryland and the surrounding area. This year’s conference covers a variety of topics including
A monoclonal antibody therapy discovery that arose from a 2005 research collaboration between scientists at the National Cancer Institute (NCI) and the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) has again been designated for human compassionate therapeutic use – this
Each year NIH Technology Transfer releases a list of the top 20 royalty-on-sales grossing products of the year based upon license agreements to inventions made by the NIH intramural research program. The list is broken down into four categories: vaccines and therapeutics, diagnostics
A novel anti-cancer therapy to target the Proviral Integration of the Moloney murine leukemia virus (PIM) kinases is available for licensing and co-development. PIM kinases are overexpressed in many solid cancers, which is predictive of poor survival in multiple cancer types. NIH inventors have